** Shares of Tylenol-maker Kenvue KVUE.N fall 6.8% to $22.07, the biggest decliner among S&P 500 .SPX constituents
** KVUE execs say at a Deutsche Bank conference that retailers have been de-stocking products in China and U.S. due to tariff-related uncertainty
** Co says the tariff environment created a lot of uncertainty for retailers, leading to immediate actions with shipments "definitely trailing consumption" in Q2
** Co expects a gross tariff impact of around $150 million for 2025, though they mentioned seeing "a slight positive on the China front" since their previous update - conf
* Kenvue expects Q2 to be "not materially different from Q1" - conf
** Including session moves, stock up 4.8% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.